Structure Therapeutics Inc. has seen limited insider activity recently, with a single proposed sale of 35,512 shares valued at approximately $1.71 million by an officer on June 25, 2026. This follows a period where the stock price experienced a 29.2% increase over the last 90 days, with the company's last earnings report released on August 5, 2026.